Abdominal Bloating Misdiagnosed as Stress Leads to Advanced Ovarian Cancer Diagnosis

Kate Ping, a 69-year-old woman from the United States, initially attributed her persistent abdominal bloating to stress and digestive issues, a common occurrence for her during high-pressure periods. However, the bloating did not subside even two months after her son's successful heart surgery, and her abdomen became so distended that the area around her navel was sensitive to touch. When she finally consulted a doctor, a nurse insisted on a CT scan, a decision Ping found unusual at the time.

The CT scan revealed the true cause: stage 4 ovarian cancer that had already spread throughout her body. "I was in complete shock," Ping told CBS News, describing her and her husband's reaction as being like "deer caught in the headlights." She had not considered cancer as a possibility, believing her symptoms were merely stress-related.

Professor Nava Zigelman-Daniely, Head of Oncology at Maccabi Healthcare Services, explained that ovarian cancer is a leading cause of death among female reproductive system cancers, with approximately 350 women diagnosed annually in Israel. Crucially, about 75% of these cases are detected at advanced stages (3 or 4) due to vague symptoms that can mimic more common ailments.

These symptoms can include persistent abdominal or pelvic swelling, abdominal or pelvic pain, feeling full quickly, and changes in bowel or urinary habits. In Ping's case, the persistent bloating was the key indicator that led to her life-altering diagnosis.

Following her diagnosis, Ping underwent chemotherapy to shrink the tumor, followed by surgery and further treatments. She later learned that the nurse who insisted on the CT scan had a personal reason: her best friend had died of ovarian cancer because it was not detected early enough. The nurse, recognizing Ping's symptoms, decided to err on the side of caution. Ping expressed her gratitude, telling the nurse, "I really think you saved my life."

Professor Zigelman-Daniely noted that advanced-stage ovarian cancer treatment often involves a combination of chemotherapy and surgery. Newer treatments, including biological therapies and PARP inhibitors, are also available for some patients, particularly those with BRCA1 or BRCA2 mutations, who have an increased risk and may benefit from preventative measures and specialized monitoring.